Video: Passengers rush to evacuate smoke-filled train
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
Raw milk sickens 21 people in Florida including 6 children
TALLAHASSEE, Fla. (AP) — Six children are among 21 people who have E. coli or campylobacter infections after consuming raw milk from a farm in Florida, public health officials said. Seven people have been hospitalized, and at least two of them are suffering severe complications, the Florida Department of Health said Monday. It did not specify if any of the six infected children under 10 are among those being treated in hospitals, nor how many people were infected by E. coli, campylobacter or both bacteria. 'Sanitation practices in this farm are of particular concern due to the number of cases,' reads the state advisory, which did not identify the farm linked to the cluster of infections in northeast and central Florida. Raw milk appears to be gaining in popularity, despite years of warnings about the health risks of drinking unpasteurized products. The Food and Drug Administration and the Centers for Disease Control and Prevention say raw milk is one of the 'riskiest' foods people can consume. Raw milk is far more likely than pasteurized milk to cause illnesses and hospitalizations because of dangerous bacteria such as campylobacter, listeria, salmonella and E. coli, research shows. The infections can cause gastrointestinal illness, and in some cases may lead to serious complications, including a life-threatening form of kidney failure. Young children, the elderly, immunocompromised people and pregnant women are at greater risk of complications. 'We invented pasteurization for a reason,' said Keith Schneider, a food safety professor at the University of Florida. 'It's maddening that this is happening.' States have widely varying regulations regarding raw milk, with some allowing retail purchases in stores and others allowing sale only at farms. Some states allow 'cowshares,' in which customers buy milk produced by designated animals, and some allow consumption only by farm owners, employees or 'non-paying guests.' In Florida, the sale and distribution of raw milk for human consumption is illegal, but retailers get around the ban by labeling their products as for pet or animal food only. Schneider called it a 'wink, wink, nudge, nudge,' form of regulation. 'Everybody knows that they're selling it for human consumption,' Schneider said, adding that people getting sick — or even seriously ill — from drinking raw milk is 'not a question of if, but when.' ___ Kate Payne is a corps member for The Associated Press/Report for America Statehouse News Initiative. Report for America is a nonprofit national service program that places journalists in local newsrooms to report on undercovered issues. Solve the daily Crossword
Fast Company
15 minutes ago
- Fast Company
Heartflow stock listing and IPO date draw near: AI-powered medtech aims for $1.3 billion valuation
It seems there's fresh blood pumping back into the IPO market. After a blowout initial public offering from Figma last week, investors might have another chance to get their heart rates up again soon. Heartflow, a California-based medtech company that utilizes AI with imaging and diagnostics software to help evaluate cardiac and coronary diseases, is looking to list shares on the Nasdaq. In paperwork filed on Friday with the Securities and Exchange Commission (SEC), Heartflow said it plans to offer 12.5 million shares, priced between $15 and $17. That could potentially raise more than $208 million. According to Reuters, Heartflow's target valuation could be as high as $1.3 billion. The company plans to trade under the ticker 'HTFL.' Subscribe to the Daily newsletter. Fast Company's trending stories delivered to you every day Privacy Policy | Fast Company Newsletters Personalized 3D-models of people's hearts Heartflow uses AI and other technology to scan patients for coronary and cardiac problems, creating three-dimensional models of patients' hearts. The Food and Drug Administration (FDA) gave the software the green light in 2022, and it's now being used in some markets to diagnose patients. Additionally, the company got a leg up last year when the U.S. Centers for Medicare and Medicaid Services (CMS) expanded Medicare coverage to include platforms that use imaging results to look for signs of coronary disease, and the American Medical Association (AMA) issued a new Category I CPT code for those platforms. That gives doctors and clinics the go-ahead to start using the technology on a broader scale starting next year. According to the company's SEC filing, Heartflow says that as of the end of March 2025, it's been used to assess more than 400,000 patients. Revenues are growing but profits are elusive Heartflow generated $125.8 million in 2024, a 44% increase over the $87.2 million it made the year before, the company says. Revenue likewise grew 39% for the first quarter of 2025 to $37.2 million. However, the company saw a net loss of $96.4 million in 2024, wider than its net loss of $95.7 million in 2023. It warns in the filing that it expects to incur 'substantial losses in the foreseeable future [and] may not be able to achieve or sustain profitability.' Bain Capital, Panorama Point Partners, and Capricorn Investment Group are among Heartflow's backers, according to Crunchbase. Bain led its most recent fundraising round, a Series F round in 2023, which raised $215 million. This is not the first time that Heartflow has attempted to go public. The company had planned to merge with a special purpose acquisition company during the SPAC frenzy of the early pandemic years, but it halted the plan in 2022, citing 'unfavorable market conditions,' as Fierce Biotech reported. Heartflow's IPO comes on the heels of another growing medtech company's public debut. Carlsmed, which specializes in AI-driven spine surgery technology, recently went public as well, with shares trading on July 23. Since then, the stock is down around 4.5%. Heartflow has not said when it plans to list its stock. Fast Company reached out for more details on the timeline and will update this post if we hear back.
Fox News
16 minutes ago
- Fox News
New study warns of plastics crisis threatening Americans' health
Fox News senior medical analyst Dr. Marc Siegel explains the risk of microplastics to human health.
